Physician profile
Jay C Proctor
NPI 1538160726
$6,004.34
in general payments reported to CMS, 2019-2025
40 companies · $917 in 2025
The $917 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $900 · 2020: $912 · 2021: $1,012 · 2022: $735 · 2023: $568 · 2024: $959 · 2025: $917.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,406 · Education: $39.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,406.00 |
| Education | $39.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,348.24 | 2021-2025 | |
| Novo Nordisk INC | $990.94 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amarin Pharma, INC. | $596.32 | 2019-2022 | |
| Pfizer INC. | $411.21 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $350.60 | 2019-2024 | Farxiga, Breztri |
| Glaxosmithkline, LLC. | $236.36 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Allergan, INC. | $212.03 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $203.83 | 2023-2025 | Voquezna |
| Amgen INC. | $186.61 | 2020-2025 | Otezla, Repatha, Otezla |
| Esperion Therapeutics, INC. | $155.76 | 2020-2025 | Nexletol |
| Merck Sharp & Dohme LLC | $125.20 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $121.41 | 2022-2025 | |
| Inspire Medical Systems, INC. | $104.15 | 2024-2025 | Inspire |
| Lilly USA, LLC | $89.12 | 2020-2025 | Zepbound, Jardiance, Mounjaro |
| Janssen Pharmaceuticals, INC | $72.34 | 2019-2020 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Proctor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.